A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Clinical trial NCT02498665 · COMPLETED

Trial details

NCT number: NCT02498665
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Glioblastoma Multiforme Melanoma Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Sarcoma Renal Cell Carcinoma

Start date: 2015-11-01
Primary completion: 2018-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.